A recent paper reveals increasing rates of diabetic retinopathy in young patients with diabetes, sparking concerns over ...

Artificial intelligence has the potential to improve ophthalmology practices by streamlining documentation, enhancing ...

The phase 3 clinical trial is a randomized, double-blind, three-arm study comparing MELT-300, sublingual midazolam, and ...

On World Sight Day, leading experts in ophthalmology look at artificial intelligence and how it could impact diagnosing and ...

MJH Life Sciences, parent company of Ophthalmology Times, has acquired The EnVision Summit. The meeting, held annually in ...

Ten of the institute's ophthalmologists will present their work in more than 20 sessions with a wide range of topics ...

According to the company, the platform accompanies the launch of Qdata Retinitis Pigmentosa for life sciences and the ...

The effort represents a consortium of researchers from Penn Medicine, Penn Engineering, the University of Michigan Kellogg ...

According to the company, a $68 million Series D financing is co-led by Arboretum Ventures and Johnson & Johnson Innovation – ...

Discover essential strategies for your practice with CareCredit. Watch our video series, Eyes on the Prize, featuring Troy Cole and Michael King. This visionary duo focuses on connecting you with ...